| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Greer G, Tolbert R |
Subjective reports of the effects of MDMA in a clinical setting |
J Psychoactive Drugs |
1986 |
| Holsten DW, Schieser DW |
Controls over the manufacture of MDMA |
J Psychoactive Drugs |
1986 |
| Stanford MW |
Designer drugs: Medical aspects and clinical management |
Alcoholism Treatment... |
1988 |
| Kunsman GW, Manno JE, Coc... |
Application of the Syva EMIT and Abbott TDx amphetamine immunoassays t... |
J Anal Toxicol |
1990 |
| Verweij AM |
Clandestine manufacture of 3,4-methylenedioxymethylamphetamine (MDMA) ... |
Forensic Sci Int |
1990 |
| Barrett PJ |
'Ecstasy' misuse--overdose or normal dose? |
Anaesthesia |
1993 |
| Sherlock K, Wolff K, Hay ... |
Analysis of illicit ecstasy tablets: implications for clinical managem... |
J Accid Emerg Med |
1999 |
| Bell SEJ, Burns DT, Denni... |
Composition Profiling of Seized Ecstasy Tablets by Raman Spectroscopy ... |
Analyst |
2000 |
| Zhao H, Brenneisen R, Sch... |
Profiles of urine samples taken from Ecstasy users at Rave parties: an... |
J Anal Toxicol |
2001 |
| Cole JC, Bailey M, Sumnal... |
The content of ecstasy tablets: implications for the study of their lo... |
Addiction |
2002 |
| Cole JC, Bailey M, Sumnal... |
The content of ecstasy tablets: implications for the study of their lo... |
Addiction |
2002 |
| Stout PR, Klette KL, Wieg... |
Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscre... |
J Anal Toxicol |
2003 |
| Sumnall HR, Evans-Brown M... |
Social, policy, and public health perspectives on new psychoactive sub... |
Drug Test Anal |
2011 |
| Bassindale T |
Benzylpiperazine: the New Zealand legal perspective |
Drug Test Anal |
2011 |
